(13) INCOME TAXES

 

For fiscal 2025 and 2024, the Company recorded no income tax expense as a result of the generation of operating losses that were subject to a full valuation allowance.

 

Deferred tax assets and liabilities are determined based on the estimated future tax effect of differences between the financial statement and tax reporting basis of assets and liabilities, as well as for, NOL carryforwards and R&D credit carryforwards, given the provisions of existing tax laws.

 

As of June 30, 2025, the Company had state NOL carryforwards of approximately $202,000,000, which will expire, if not utilized, between 2036 and 2045, federal NOL carryforwards of approximately $151,000,000 and federal R&D credits of approximately $10,000,000, which expire, if not utilized, between 2035 and 2045, and foreign tax credits of $582,500, which expire, if not utilized, in 2028.

 

In assessing the realizability of deferred tax assets, the Company considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income and the application of loss limitation provisions related to ownership changes. The Company assesses the available positive and negative evidence to estimate if sufficient future taxable income will be generated to use the existing deferred tax assets. The Company also considers the scheduled reversal of deferred tax liabilities (including the impact of available carryback and carryforward periods), projected future taxable income, and tax‑planning strategies in making this assessment. Based on a history of losses incurred, the Company has recognized a full valuation allowance against its deferred tax assets during the years ended June 30, 2025 and 2024. The Company’s valuation allowance increased by $7,591,000 and $11,193,000 for the years ended June 30, 2025 and 2024, respectively.

 

A sustained period of profitability in the Company’s operations is required before it would change its judgment regarding the need for a full valuation allowance against its net deferred tax assets. Until such time, the use of NOL carryforwards and tax credits to offset profits, if any, will reduce the overall level of deferred tax assets subject to valuation allowance.

 

The Tax Reform Act of 1986 (the “Tax Reform Act”) provides for limitation on the use of the Company’s NOL and R&D tax credit carryforwards following certain ownership changes (as defined by the Tax Reform Act) that could limit the Company’s ability to utilize these carryforwards. Since its inception, the Company has completed several financings and sales of common stock which has resulted in multiple ownership changes defined by Section 382 of the Tax Reform Act. Accordingly, the Company’s ability to utilize the aforementioned carryforwards are subject to limitation under Section 382.

 

If the Company undergoes a future ownership change or as it completes its Section 382 limitation assessments, any unutilized carryforwards that were not previously subject to a Section 382 limitation may become subject to limitation which may result in a significant limitation and loss of NOL carryforwards and R&D credits.

 

Additionally, U.S. tax laws limit the time during which these carryforwards may be applied against future taxes; therefore, the Company may not be able to take full advantage of these carryforwards for federal income tax purposes. Accordingly, a portion of the carryforwards may expire unutilized.

 

The Company’s net deferred tax assets are as follows:

 

 

 

June 30,

 

 

June 30,

 

 

 

2025

 

 

2024

 

Net operating loss carryforwards

 

$46,054,000

 

 

$40,051,000

 

Research and development and AMT tax credits

 

 

9,995,000

 

 

 

9,464,000

 

Foreign tax credits

 

 

583,000

 

 

 

583,000

 

Basis differences in fixed assets and other

 

 

13,668,000

 

 

 

12,611,000

 

 

 

 

70,300,000

 

 

 

62,709,000

 

Valuation allowance

 

 

(70,300,000)

 

 

(62,709,000)

Net deferred tax assets

 

$-

 

 

$-

 

 

The Company recognizes interest expense and penalties on uncertain income tax positions as a component of interest expense. No interest expense or penalties were recorded for uncertain income tax matters in fiscal 2025 or 2024. As of June 30, 2025 and 2024, the Company had no liabilities for uncertain income tax matters.

About Income Taxes Disclosures

The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.

Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.